Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01050075 · ClinicalTrials.gov registry record · NA
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A NA study, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01050075 is a NA study that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT01050075, a NA study, was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
RATIONALE: Acupuncture may help relieve nerve pain caused by chemotherapy. PURPOSE: This randomized clinical trial is studying how well acupuncture works in treating nerve pain in patients with stage I, stage II, and stage III breast cancer who are receiving paclitaxel.
Interventions
- OTHER questionnaire administration
- OTHER management of therapy complications
- OTHER acupuncture therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01050075
The ClinicalTrials.gov registry entry for NCT01050075 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01050075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01050075 about?
NCT01050075 is a clinical study titled "Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel". RATIONALE: Acupuncture may help relieve nerve pain caused by chemotherapy. PURPOSE: This randomized clinical trial is studying how well acupuncture works in treating nerve pain in patients with stage I, stage II, and stage III breast cancer who are receiving paclitaxel.
What is the current status of trial NCT01050075?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2010-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01050075?
The interventions under investigation include: questionnaire administration (OTHER), management of therapy complications (OTHER), acupuncture therapy (OTHER).
Who is sponsoring clinical trial NCT01050075?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.